Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.57
AMRS's Cash to Debt is ranked higher than
72% of the 1109 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.38 vs. AMRS: 0.57 )
AMRS' s 10-Year Cash to Debt Range
Min: 0.1   Max: No Debt
Current: 0.57

Equity to Asset -0.70
AMRS's Equity to Asset is ranked lower than
64% of the 1104 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.51 vs. AMRS: -0.70 )
AMRS' s 10-Year Equity to Asset Range
Min: -0.93   Max: 0.87
Current: -0.7

-0.93
0.87
F-Score: 4
Z-Score: -6.14
M-Score: -1.60
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 1/10

vs
industry
vs
history
Operating margin (%) -206.94
AMRS's Operating margin (%) is ranked lower than
63% of the 1120 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.87 vs. AMRS: -206.94 )
AMRS' s 10-Year Operating margin (%) Range
Min: -312.41   Max: -98.14
Current: -206.94

-312.41
-98.14
Net-margin (%) -414.47
AMRS's Net-margin (%) is ranked lower than
63% of the 1120 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.95 vs. AMRS: -414.47 )
AMRS' s 10-Year Net-margin (%) Range
Min: -571.78   Max: -99.77
Current: -414.47

-571.78
-99.77
ROA (%) -83.10
AMRS's ROA (%) is ranked lower than
64% of the 1121 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.86 vs. AMRS: -83.10 )
AMRS' s 10-Year ROA (%) Range
Min: -106.46   Max: -34.14
Current: -83.1

-106.46
-34.14
ROC (Joel Greenblatt) (%) -70.01
AMRS's ROC (Joel Greenblatt) (%) is ranked lower than
62% of the 1120 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 10.19 vs. AMRS: -70.01 )
AMRS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -297.97   Max: -78.77
Current: -70.01

-297.97
-78.77
Revenue Growth (%) -53.60
AMRS's Revenue Growth (%) is ranked lower than
62% of the 953 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.60 vs. AMRS: -53.60 )
AMRS' s 10-Year Revenue Growth (%) Range
Min: 0   Max: -53.6
Current: -53.6

EBITDA Growth (%) -18.60
AMRS's EBITDA Growth (%) is ranked lower than
52% of the 881 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.70 vs. AMRS: -18.60 )
AMRS' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: -18.6
Current: -18.6

EPS Growth (%) -28.00
AMRS's EPS Growth (%) is ranked lower than
51% of the 798 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.70 vs. AMRS: -28.00 )
AMRS' s 10-Year EPS Growth (%) Range
Min: 0   Max: -28
Current: -28

» AMRS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2012

AMRS Guru Trades in Q4 2012

Paul Tudor Jones 20,600 sh (New)
» More
Q1 2013

AMRS Guru Trades in Q1 2013

Paul Tudor Jones 11,600 sh (-43.69%)
» More
Q2 2013

AMRS Guru Trades in Q2 2013

Paul Tudor Jones 11,600 sh (unchged)
» More
Q3 2013

AMRS Guru Trades in Q3 2013

Paul Tudor Jones Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with AMRS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 5.20
AMRS's P/S is ranked lower than
55% of the 1165 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.10 vs. AMRS: 5.20 )
AMRS' s 10-Year P/S Range
Min: 0.52   Max: 9.69
Current: 5.2

0.52
9.69
EV-to-EBIT -2.97
AMRS's EV-to-EBIT is ranked lower than
52% of the 1165 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 19.10 vs. AMRS: -2.97 )
AMRS' s 10-Year EV-to-EBIT Range
Min: -14.6   Max: -0.2
Current: -2.97

-14.6
-0.2
Current Ratio 2.36
AMRS's Current Ratio is ranked higher than
81% of the 1116 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.75 vs. AMRS: 2.36 )
AMRS' s 10-Year Current Ratio Range
Min: 0.54   Max: 11.36
Current: 2.36

0.54
11.36
Quick Ratio 1.98
AMRS's Quick Ratio is ranked higher than
84% of the 1116 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.20 vs. AMRS: 1.98 )
AMRS' s 10-Year Quick Ratio Range
Min: 0.37   Max: 11.22
Current: 1.98

0.37
11.22

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 1.47
AMRS's Price/Median PS Value is ranked higher than
55% of the 1165 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.16 vs. AMRS: 1.47 )
AMRS' s 10-Year Price/Median PS Value Range
Min: 0.36   Max: 2.78
Current: 1.47

0.36
2.78
Earnings Yield (Greenblatt) -33.70
AMRS's Earnings Yield (Greenblatt) is ranked lower than
64% of the 1104 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.70 vs. AMRS: -33.70 )
AMRS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0   Max: 0
Current: -33.7

Business Description

Industry: Chemicals » Specialty Chemicals
Compare: » details
Traded in other countries:3A0.Germany
Amyris Inc was incorporated in California on July 17, 2003 and reincorporated in Delaware on June 10, 2010. The Company is a renewable products company engaged in providing sustainable alternatives to petroleum-sourced products. It developed microbial engineering and screening technologies that modify the way microorganisms process sugars. The Company is engaged in in developing various products to address five identified markets: cosmetics, flavors and fragrances, performance materials, lubricants and transportation fuels. The Company is using its proprietary synthetic biology platform to design microbes, mainly yeast, and use them as living factories in established fermentation processes to convert plant-sourced sugars into renewable hydrocarbons. The Company is developing, and, in some cases, already commercializing, products from these hydrocarbons in several target markets, including cosmetics, lubricants, flavors and fragrances, performance materials, and transportation fuels. It calls these No Compromise products because it design them to perform comparably to, or better than, currently available products. The Company's first commercialization efforts have been focused on a renewable hydrocarbon molecule called farnesene Biofene, which forms the basis for various products varying from specialty chemical applications to transportation fuels, such as diesel. In addition, the Company has entered into various contract manufacturing agreements to support commercial production. The Company has established two main operating subsidiaries, Amyris Brasil Ltda. for production in Brazil, and Amyris Fuels, LLC. As of January 31, 2014, the Company had 247 issued U.S. and foreign patents and 327 pending U.S. and foreign patent applications that are owned by or licensed to it. The Company is subject to a various federal, state, local and international laws, regulations and permit requirements governing the use, generation, manufacture, transportation, storage, handling and disposal of these materials in the United States, Brazil and other countries where it operates.
» More Articles for AMRS

Headlines

Articles On GuruFocus.com
Weekly CEO Sells Highlight: Netlist Inc, LifePoint Hospitals Inc, Amyris Inc, and Sapient Corp. May 25 2014 
Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
Weekly CEO Sells Highlight: Amyris, AtriCure, 3D Systems Corporation and Cooper Tire & Rubber Compan Sep 10 2012 
Weekly CFO Sells Highlight: SCHW, TIBX, IL, AMRS, BCR, CCOI, CBST Apr 24 2011 
Weekly CEO Sells Highlight: MU, CRIS, HIL, and AMRS Apr 03 2011 

More From Other Websites
AMYRIS, INC. Financials Nov 15 2014
Amyris Launches Second Innovative and Renewable Ingredient for Cosmetics Industry Nov 10 2014
Amyris Launches Second Innovative and Renewable Ingredient for Cosmetics Industry Nov 10 2014
10-Q for Amyris, Inc. Nov 09 2014
AMYRIS, INC. Files SEC form 10-Q, Quarterly Report Nov 07 2014
Amyris misses 3Q revenue forecasts Nov 04 2014
Amyris misses 3Q revenue forecasts Nov 04 2014
AMYRIS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 04 2014
Amyris Reports Third Quarter 2014 Financial Results Nov 04 2014
Q3 2014 Amyris Inc Earnings Release - After Market Close Nov 04 2014
Amyris Receives Green Chemistry Innovation Award From U.S. Environmental Protection Agency Oct 16 2014
Amyris to Announce Third Quarter Financial Results on Tuesday, November 4, 2014 Oct 13 2014
Braskem Joins Amyris and Michelin to Accelerate the Industrialization and Commercialization of... Sep 09 2014
Using Mean Reversion and Momentum for Possible Advantage Aug 30 2014
Can Amyris (AMRS) Run Higher on Strong Earnings Estimate Revisions? Aug 26 2014
Amyris (AMRS) Shares March Higher, Can It Continue? Aug 22 2014
Total-Backed Amyris Gets $11 Million for Research on Farnesene Aug 14 2014
AMYRIS, INC. Files SEC form 10-Q, Quarterly Report Aug 08 2014
AMYRIS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 07 2014
AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Aug 04 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK